These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of nonprescription dietary supplements for weight loss is common among Americans. Blanck HM; Serdula MK; Gillespie C; Galuska DA; Sharpe PA; Conway JM; Khan LK; Ainsworth BE J Am Diet Assoc; 2007 Mar; 107(3):441-7. PubMed ID: 17324663 [TBL] [Abstract][Full Text] [Related]
24. Short-term and long-term in vivo exposure to an ephedra- and caffeine-containing metabolic nutrition system does not induce cardiotoxicity in B6C3F1 mice. Ray S; Phadke S; Patel C; Hackman RM; Stohs S Arch Toxicol; 2005 Jun; 79(6):330-40. PubMed ID: 15895207 [TBL] [Abstract][Full Text] [Related]
25. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium). Nelson BC; Putzbach K; Sharpless KE; Sander LC J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980 [TBL] [Abstract][Full Text] [Related]
26. A critical evaluation of Internet marketing of products that contain ephedra. Ashar BH; Miller RG; Getz KJ; Pichard CP Mayo Clin Proc; 2003 Aug; 78(8):944-6. PubMed ID: 12911041 [TBL] [Abstract][Full Text] [Related]
27. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Fugh-Berman A; Myers A Exp Biol Med (Maywood); 2004 Sep; 229(8):698-704. PubMed ID: 15337824 [TBL] [Abstract][Full Text] [Related]
28. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994. Seamon MJ; Clauson KA J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299 [TBL] [Abstract][Full Text] [Related]
29. Addressing the potential risks associated with ephedra use: a review of recent efforts. Schulman S Public Health Rep; 2003; 118(6):487-92. PubMed ID: 14563905 [TBL] [Abstract][Full Text] [Related]
30. Protecting consumers in the wake of the U.S. Dietary Supplement Health and Education Act. Foote JC J Allied Health; 2007; 36(1):57-60. PubMed ID: 17425193 [TBL] [Abstract][Full Text] [Related]
31. Amphetamine lacing of an Internet-marketed neutraceutical. Nguyen MH; Ormiston T; Kurani S; Woo DK Mayo Clin Proc; 2006 Dec; 81(12):1627-9. PubMed ID: 17165642 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the stimulant content of dietary supplements marketed as "ephedra-free". Gregory PJ J Herb Pharmacother; 2007; 7(1):65-72. PubMed ID: 17594988 [TBL] [Abstract][Full Text] [Related]
33. Time to ban ephedra--now. Guharoy R; Noviasky JA Am J Health Syst Pharm; 2003 Aug; 60(15):1580-2. PubMed ID: 12951759 [No Abstract] [Full Text] [Related]
34. Reporting associations between dietary supplements and adverse events. McGuffin M Mayo Clin Proc; 2006 Dec; 81(12):1636; author reply 1636-7. PubMed ID: 17165644 [No Abstract] [Full Text] [Related]
35. FDA to ban sales of dietary supplements containing ephedra. Ling AM J Law Med Ethics; 2004; 32(1):184-6. PubMed ID: 15152444 [No Abstract] [Full Text] [Related]
36. FDA v. ephedra: is it time to lift the ban? Pyle KR Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770 [No Abstract] [Full Text] [Related]
37. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain? Allison DB; Cutter G; Poehlman ET; Moore DR; Barnes S Int J Obes (Lond); 2005 Apr; 29(4):443-6. PubMed ID: 15700046 [TBL] [Abstract][Full Text] [Related]
38. Long term exposure effect of a unique metabolic nutrition system containing a diverse group of phytochemicals on serum chemistry and genomic and non-genomic changes in the liver of female B6C3F1 mice. Ray SD; Parmar M; Syed I; Rathod J; Zinkovsky D; Bulku E; Gigliotti J; Hackman RM; Stohs SJ Phytother Res; 2008 Apr; 22(4):458-71. PubMed ID: 18386253 [TBL] [Abstract][Full Text] [Related]